Processes and host cells for genome, pathway, and biomolecular engineering
申请人:enEvolv, Inc.
公开号:US10370654B2
公开(公告)日:2019-08-06
The present disclosure provides compositions and methods for genomic engineering.
本公开提供了基因组工程的组合物和方法。
PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING
申请人:ENEVOLV, INC.
公开号:US20160186168A1
公开(公告)日:2016-06-30
The present disclosure provides compositions and methods for genomic engineering.
US9944925B2
申请人:——
公开号:US9944925B2
公开(公告)日:2018-04-17
[EN] THERAPEUTIC RELEASE AGENTS<br/>[FR] AGENTS DE LIBÉRATION THÉRAPEUTIQUES
申请人:ORGANON NV
公开号:WO2008100977A2
公开(公告)日:2008-08-21
[EN] Pharmacological inhibition of fatty acid amide hydrolase (FAAH) activity leads to increased levels of fatty acid amides. Esters of alkylcarbamic acids are disclosed that are inhibitors of FAAH activity. Compounds disclosed herein inhibit FAAH activity. Described herein are processes for the preparation of esters of alkylcarbamic acid compounds, compositions that include them, and methods of use thereof. [FR] L'inhibition pharmacologique de l'activité de l'amide hydrolase d'acides gras (FAAH) entraîne une augmentation des taux d'amides d'acides gras. L'invention concerne des esters d'acides alkylcarbamiques qui constituent des inhibiteurs de l'activité de la FAAH. Les composés décrits inhibent l'activité de la FAAH. L'invention concerne aussi des procédés de préparation d'esters de composés d'acides alkylcarbamiques, des compositions renfermant ceux-ci et des procédés d'utilisation de celles-ci.
Naturally occurring Batatasins and their derivatives as α-glucosidase inhibitors
作者:Wei-ping Hu、Guo-dong Cao、Jin-hua Zhu、Jia-zhong Li、Xiu-hua Liu
DOI:10.1039/c5ra15328j
日期:——
Naturally occurred Batatasins and derivatives displayed remarkable inhibitory effects against α-glucosidase, which provide promising chemical scaffolds for antidiabetic drug development.